Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD

Shahid Beheshti University of Medical Sciences

Status and phase: Unknown; Phase 3

Conditions: Neovascular Age-Related Macular Degeneration

Treatments: Drug: verteporfin, bevacizumab, triamcinolone acetonide

Study type: Interventional

Funder types: Other

Identifiers

NCT00370539

8542

Details and patient eligibility

About

To compare the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal bevacizumab versus combination of photodynamic therapy , intravitreal bevacizumab and intravitreal triamcinolone for neovascular AMD.

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cases of active neovascular AMD with visual acuity of 20/400- 20/40

Exclusion criteria

• History of glaucoma or ocular hypertension
• Disciform scar

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind